ArticleBiomedicines2025

GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation.

Congcong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.